Cash-Burning Biotechs Turn to Debt to Help Chase Covid Cures
3 min readBiotech companies have taken center stage during the pandemic of 2020. Between the many vaccine initiatives and even more numerous investments in testing and new Covid-19 therapies, money is flooding into the sector at a record rate. Biotechs raised more than $6 billion in initial public offerings in just the first half of the year….